HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Sodium borohydride → 1-{6-[(6-Ethoxy-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]urea

HRID 517811
Print

Reaction equation

HRID 517811 reaction equation
[BH4-].[Na+].[CH2:3]([O:5][C:6]1[CH:7]=[CH:8][C:9]2[N:10]([C:12]([S:15][C:16]3[CH:36]=[CH:35][C:19]4[N:20]=[C:21]([NH:23][C:24]([NH:26][CH2:27][CH2:28][N:29]5[CH2:34][CH2:33][O:32][CH2:31][CH2:30]5)=[O:25])[S:22][C:18]=4[CH:17]=3)=[N:13][N:14]=2)[N:11]=1)[CH3:4]>C(O)C>[CH2:3]([O:5][C:6]1[CH2:7][CH2:8][C:9]2[N:10]([C:12]([S:15][C:16]3[CH:36]=[CH:35][C:19]4[N:20]=[C:21]([NH:23][C:24]([NH:26][CH2:27][CH2:28][N:29]5[CH2:30][CH2:31][O:32][CH2:33][CH2:34]5)=[O:25])[S:22][C:18]=4[CH:17]=3)=[N:13][N:14]=2)[N:11]=1)[CH3:4]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

4

Reactant 2

HCID 4311764Sodium borohydride2×HCID 425986581-{6-[(6-Ethoxy[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]urea

Product 1

HCID 425986591-{6-[(6-Ethoxy-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]ureaYield 40.1%

Reagents, catalysts & solvents 1

HCID 702
Ethanol
Solvent

Procedure

27 mg of sodium borohydride are added to a mixture of 179 mg of 1-{6-[(6-ethoxy[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]urea in 10 cm3 of ethanol. The reaction is refluxed for 3.5 h, and then 108 mg of sodium borohydride are added gradually and the reflux is maintained for 48 h. The reaction mixture is concentrated to dryness under reduced pressure. The residue is purified by chromatography on Biotage Quad 12/25 (KP-SIL, 60 A; 32-63 mM), elution being carried out with a dichloromethane/methanol gradient of 99/1 to 93/7. 72 mg of 1-{6-[(6-ethoxy-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]urea are thus obtained in the form of a white powder, the characteristics of which are as follows:

Workup

  1. temperatureThe reaction is refluxed for 3.5 h
  2. temperaturethe reflux is maintained for 48 h
  3. concentrationThe reaction mixture is concentrated to dryness under reduced pressure
  4. customThe residue is purified by chromatography on Biotage Quad 12/25 (KP-SIL, 60 A
  5. wash32-63 mM), elution

Sources & evidence

ORD record
ord-5aee6e30b413414e9bc4241d23144dc9
Source dataset
uspto-grants-2015_08
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US09115134B2

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes